Sign in
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022
Cystoid Macular Edema after Retinectomy for Proliferative Vitreoretinopathy
Yodpong Chantarasorn, MD
On Demand Cases, Courses, and Papers
2019
Adjunctive Focal Laser Following Central Fluid Resolution After Bevacizumab, Ranibizumab, or Aflibercept Injection: A Secondary Analysis of Protocol T
Jennifer R Gallagher, MD
Annual Meeting Talks
2020
Category: Pharmacology